JPRN-UMIN000023361
Completed
N/A
A Phase II Study of Short-course Radiotherapy Preoperatively followed by Capecitabine and Oxaliplatin (XELOX) for cT3 Node-positive Lower Rectal Cancer - ADVANCE-RC study
Cancer Institute Hospital of Japanese Foundation for Cancer Research0 sites28 target enrollmentAugust 1, 2016
Conditionsow rectal cancer
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- ow rectal cancer
- Sponsor
- Cancer Institute Hospital of Japanese Foundation for Cancer Research
- Enrollment
- 28
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\. cT4 or cN2\. 2\. CRM less than 1mm. 3\. Administration contraindication of oxaliplatin or capecitabine. 4\. History of the serious hypersensitivity for any agents. 5\. History of pelvic irradiation. 6\. Uncontrolled active infection. 7\. Clinically significant complication (heart failure, interstitial lung disease or pulmonary fibrosis, uncontrolled diabetes, renal failure, liver failure, etc.) 8\. Evidence of peripheral sensory neuropathy. 9\. Uncontrolled diarrhea. 10\. Uncontrolled pleural effusion or ascites. 11\. Multiple primary cancer within 5 years. 12\. Possible pregnant, pregnant or breast\-feeding female. 13\. Other conditions not suitable for this study.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
N/A
Effect of short-course radiotherapy followed by neoadjuvant Xelox (Capecitabine and Oxaliplatin) chemotherapy and total mesorectal excision in MRI defined high-risk rectal cancer: A phase II trialKCT0003367Yonsei University Health System, Severance Hospital31
Recruiting
Phase 2
A phase II study of combination of radiotherapy and Atezolizumab/nab-paclitaxel for inoperable or recurrent PD-L1 positive triple negative breast cancerinoperable or recurrent PD-L1 positive triple negative breast cancerJPRN-jRCTs021210010Suzuki Yoshiyuki20
Active, Not Recruiting
Phase 1
Phase I/IIa study of concomitant radiotherapy with olaparib and temozolomide in unresectable high grade gliomas patientsEUCTR2016-003468-38-FRCentre François baclesse
Active, Not Recruiting
N/A
Phase II study of definitive radiochemotherapy for locally advanced squamous cell cancer of the vulva: an efficacy study - radiotherapy for vulvar canceradvanced stage squamous cell cancer of the vulvaMedDRA version: 8.1Level: LLTClassification code 10047777Term: Vulvar cancerEUCTR2006-004052-20-NLKoningin Wilhelmina Fonds
Completed
Phase 2
Phase II study of definitive radiochemotherapy for locally advanced squamous cell cancer of the vulva: an efficacy studyvulvar cancervulvar neoplasm1003859710029903NL-OMON30199Academisch Medisch Centrum68